House Bill 5329
115th Congress(2017-2018)
Poison Center Network Enhancement Act of 2018
Active
Passed House on Jun 12, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5329
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on June 12, 2018
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5057-5058)
Summary
Poison Center Network Enhancement Act of 2018
This bill amends the Public Health Service Act to reauthorize for FY2020-FY2024 and revise the national toll-free phone number, public awareness campaign, and grant program relating to poison control centers. Among other changes, the bill:
- supports enhancements of the national toll-free phone number, such as texting capabilities and improved location accuracy;
- expands the public awareness campaign to include education about information that is available from poison control centers regarding drug misuse; and
- authorizes poison control centers and professional organizations to use grant funds for preventing and treating the misuse of opioids and other drugs.
06/13/2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
06/12/2018
Motion to reconsider laid on the table Agreed to without objection.
06/12/2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5057-5058)
06/12/2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5057-5058)
06/12/2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5329.
06/12/2018
Considered under suspension of the rules. (consideration: CR H5057-5059)
06/12/2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
05/17/2018
Ordered to be Reported (Amended) by Voice Vote.
05/17/2018
Committee Consideration and Mark-up Session Held.
04/25/2018
Forwarded by Subcommittee to Full Committee by Voice Vote .
04/25/2018
Subcommittee Consideration and Mark-up Session Held.
04/25/2018
Referred to the Subcommittee on Health.
03/19/2018
Referred to the House Committee on Energy and Commerce.
03/19/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:40:11 PM